These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 11444079

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harpe K.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):269-73. PubMed ID: 15059505
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Osteoporosis and fracture risk in women of different ethnic groups.
    Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, Santora AC, Sherwood LM.
    J Bone Miner Res; 2005 Feb 17; 20(2):185-94. PubMed ID: 15647811
    [Abstract] [Full Text] [Related]

  • 27. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL, He JW, Qin YJ, Huang QR, Liu YJ, Hu YQ, Li M.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr 17; 23(2):129-33. PubMed ID: 16604479
    [Abstract] [Full Text] [Related]

  • 28. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.
    Bone; 2004 Apr 17; 34(4):728-35. PubMed ID: 15050905
    [Abstract] [Full Text] [Related]

  • 29. Identification of the risk factors for osteoporosis among postmenopausal women.
    Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, Karacay O, Deveci S.
    Maturitas; 2008 Apr 17; 60(3-4):253-6. PubMed ID: 18778903
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA, Berger ML, Santora AC, Sherwood LM.
    Menopause; 2003 Apr 17; 10(5):412-9. PubMed ID: 14501602
    [Abstract] [Full Text] [Related]

  • 33. The role of the primary care physician in diagnosis and management of osteoporosis.
    Wehren LE.
    Int J Fertil Womens Med; 2002 Apr 17; 47(3):116-22. PubMed ID: 12081256
    [Abstract] [Full Text] [Related]

  • 34. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
    van der Voort DJ, Brandon S, Dinant GJ, van Wersch JW.
    Osteoporos Int; 2000 Apr 17; 11(3):233-9. PubMed ID: 10824239
    [Abstract] [Full Text] [Related]

  • 35. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I, World Health Organization.
    Clin Calcium; 2007 Jul 17; 17(7):1090-6. PubMed ID: 17607077
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women.
    Marci CD, Anderson WB, Viechnicki MB, Greenspan SL.
    Calcif Tissue Int; 2000 Feb 17; 66(2):113-8. PubMed ID: 10652958
    [Abstract] [Full Text] [Related]

  • 38. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures.
    Nguyen TV, Jones G, Sambrook PN, White CP, Kelly PJ, Eisman JA.
    J Clin Endocrinol Metab; 1995 Sep 17; 80(9):2709-14. PubMed ID: 7673413
    [Abstract] [Full Text] [Related]

  • 39. Improving clinical decisions for women at risk of osteoporosis: dual-femur bone mineral density testing.
    Cole RE.
    J Am Osteopath Assoc; 2008 Jun 17; 108(6):289-95. PubMed ID: 18587077
    [Abstract] [Full Text] [Related]

  • 40. Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women.
    Palacios S, Neyro JL, Fernández de Cabo S, Chaves J, Rejas J.
    Climacteric; 2014 Feb 17; 17(1):60-70. PubMed ID: 23710562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.